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Objectives This study investigated the effects of 17-estradiol (E2) on gene regulation in human cardiac tissues. We hy-
pothesized that a candidate E2 effect is cardiomyocyte (CM)- and sex-specific, conserved between humans and
mice, and that E2 impairs contractile function in male CMs only.
Background Both men and women produce E2 locally from androgenic precursors. E2 regulates cardiovascular function, but
specific mechanisms, protective or harmful, are not fully understood.
Methods We performed genome-wide expression profiling of E2-treated cardiac tissues from men and women, and stud-
ied gene expression and function in CMs from hearts of male and female E2-treated mice.
Results We found 36 E2-dependent genes regulated in a sex-specific manner. Of these, after E2 exposure, the myosin regulatory
light chain interacting protein (MYLIP) gene was induced in tissues of men only. Focusing on Mylip and employing isolated
mouse CMs, we confirmed our hypotheses that the E2 effect is CM- and sex-specific and conserved between humans and
mice. The E2-treatment led to impaired contractile function in male CMs only, which was characterized by increased Mylip
mRNA and protein levels, and decreased myosin regulatory light chain (Mrlc) protein. Our report is the first to our knowl-
edge to show that cardiac Mrlc is an in vivo substrate for Mylip, leading to augmented Mrlc ubiquitination. Of relevance, we
found thatMYLIP expression levels rise with increasing age in hearts of men.
Conclusions E2 directly influences cardiac gene regulation, and E2 actions may be different between the sexes. Since E2 lev-
els rise in older and/or obese men, pharmacological targeting of MYLIP in men with elevated E2 levels could
possibly decrease their risk for the development or progression of cardiovascular disease. (J Am Coll Cardiol
2012;59:410–7) © 2012 by the American College of Cardiology Foundation
Published by Elsevier Inc. doi:10.1016/j.jacc.2011.09.054Sex- and menopause-related differences in cardiovascular
diseases have drawn considerable attention to the sex steroid
hormone 17-estradiol (E2), which has been largely be-
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accepted September 13, 2011.lieved to be beneficial for the heart (1). However, unex-
pected negative findings from large randomized clinical
trials (2,3) and conflicting results from animal studies have
led to controversy about the role and actions of E2.
Additionally, recent studies have revealed that E2 is also
relevant for cardiovascular function in men (4). A better
understanding of the effects of E2 on molecular and cellular
physiology in the cardiovascular system is necessary.
See page 418
The primary source of E2 production is the ovary.
However, E2 is also produced locally in both sexes through
the conversion of testosterone by aromatase (5), with the
adipose tissue contributing significantly to its circulating
pool (6). E2 modulates a number of biological processes,
such as reproduction, development, cell proliferation, dif-
c
w
s
E
i
o
t
E
R
a
e
H
c
a
p
E
M
w
c
r
M
a
m
2
L
w
m
w
a
b
w
a
o
a
m
c
5
w
M
D
s
o
Q
t
s
I
p
S
u
m
f
u
a
s
R
E
c
h
f
p
t
e
g
w
u
(
411JACC Vol. 59, No. 4, 2012 Kararigas et al.
January 24, 2012:410–7 E2-Induced Mylip in Male CMs Impairs Contractionferentiation, apoptosis, and metabolism, via gene regulation.
E2 directly influences gene expression through the classical
cytosolic estrogen receptors (ER)  and , although rapid
nongenomic actions not requiring the ER have also been
reported. In the genomic effects, E2 binds to the ER, and
the newly formed complex translocates to the nucleus.
Subsequently, E2-ER complexes interact with a number of
coactivator and corepressor proteins that are recruited to the
receptor after ligand binding, to mediate or inhibit tran-
scription (7,8).
We investigated the effect of E2 on the regulation of gene
expression in human cardiac tissues. Following genome-
wide expression profiling, we selected myosin regulatory
light chain interacting protein (Mylip) as our candidate, and
we tested the hypothesis that this estrogenic effect occurs in
the cardiomyocyte (CM) using isolated CMs from hearts of
E2-treated mice. We found that the effect is conserved
between humans and mice, and that E2 modulates the
expression of Mylip to control cellular contraction. We have
therefore identified an effect of E2 on the regulation of gene
expression occurring directly in the CM. This effect differs
between the sexes, and we report that E2 impairs contractile
function in male, but not in female, CMs. Notably, we also
found that MYLIP expression is higher in the hearts of men
older than 50 years than in the hearts of men younger than
40 years. Considering that E2 levels rise in older and/or
obese men and, particularly, that elevated E2 levels in men
with heart failure are associated with poor prognosis (4), our
findings could be clinically relevant. Further confirmation of
these findings at a clinical level could help to develop
sex-specific treatments as part of a more individualized
medical care, tailored to the specific needs of men and
women.
Methods
Human cardiac tissue studies. Tissue harvest, culture, and
treatment were recently described (9) and are summarized in
the Online Methods. Tissues from 6 patients (50% women)
undergoing coronary bypass surgery were treated with 108
mol/l E2 or 2-hydroxypropyl--cyclodextrin (HBC) (vehi-
le control for E2 treatment) for 24 h. This concentration
as chosen to obtain an E2 level of physiological range. The
tudy was approved by the Charite University Hospital
thics Committee, it complies with the principles outlined
n the Declaration of Helsinki, and written consent was
btained.
Nondiseased male human hearts (n  6 for age 40
years, n  9 for age 50 years) technically unusable for
ransplantation were obtained from general organ donors.
xperimental protocols were approved by the Scientific and
esearch Ethical Committee of the Medical Scientific Board
t the Hungarian Ministry of Health (ETT-TUKEB) under
thical approval No. 4991-0/2010-1018EKU (339/PI/010).
ybridization and microarray profiling. Detailed proto-ols are provided in the Online Methods. Microarray data tre deposited in the ArrayEx-
ress database (accession No.
-MEXP-2971).
icroarray data analysis. Data
ere analyzed as described re-
ently (10,11) and as summa-
ized in the Online Methods.
ouse experiments. Middle-
ged (11- to 14-month-old)
ale (n  20) and female (n 
2) C57BL/6J mice (Charles River
aboratories, Sulzfeld, Germany)
ere treated in vivo with 0.2
g/kg E2, a dose reported to lead
ithin 2 h to a 2.5-fold increase in E2 levels up to 129 pg/ml
nd within the physiological range for mice, returning to
aseline after 22 h as E2 gets metabolized (12). Control mice
ere treated with HBC. The peak serum levels in elderly men
re also reported to be up to 129 pg/ml, supporting the choice
f E2 dose (13). Five hours after injection, mice were sacrificed
nd divided into 2 sets. In the first set (n  4 male HBC, 6
ale E2, 5 female HBC, 7 female E2), CMs were isolated for
ontraction and mRNA measurements. The second set (n 
/group) was used to extract protein. Unloaded cell shortening
as measured with a video-edge detector (Ionoptix, Milton,
assachusetts) at 1, 2, and 4 Hz using field stimulation.
etailed protocols are provided in the Online Methods. The
tudy was approved by the Ethics Committee on Animal Use
f the University of Leuven.
uantitative real-time reverse transcription PCR. Reac-
ions were performed as described previously (9) and as
ummarized in the Online Methods.
mmunoblotting and coimmunoprecipitation. Detailed
rotocols are provided in the Online Methods.
tatistical analysis. All data were analyzed statistically
sing the R version 2.11.0 software. Data are shown as the
ean  SEM. Comparisons between 2 groups were per-
ormed with unpaired t test and between multiple groups
sing 2-way analysis of variance with Tukey’s post-hoc test
djusting for multiple comparisons, considering p  0.05
ignificant.
esults
2-dependent regulation of gene expression in human
ardiac tissues. To investigate the effects of E2 on global
uman cardiac gene expression, we treated heart tissues
rom men and women with E2 or HBC (vehicle), and we
erformed microarray analysis. After verifying the quality of
he microarray data, we fitted a linear model with an
mpirical Bayesian method (14) to determine differential
ene expression. To extract biologically useful information,
e examined those probe sets with an unadjusted p value of
p to 0.001. This resulted in 77 significant probe sets
Online Table 1). Unsupervised hierarchical clustering of
Abbreviations
and Acronyms
CM  cardiomyocyte
E2  17-estradiol
ER  estrogen receptor
HBC  2-hydroxypropyl-
-cyclodextrin
Mrlc  myosin regulatory
light chain
Mylip  myosin regulatory
light chain interacting
proteinhese probe sets revealed that the treatment with E2 was not
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distinct groups, i.e., E2 and HBC, suggesting that the sex
might play an important role in the regulation of gene
expression by E2 (Fig. 1). Additionally, we found that there
Figure 1 Heat Map of E2-Regulated
Human Cardiac Gene Expression
Tissues were treated with 108 mol/l E2 or HBC (vehicle) for 24 h followed by
microarray analysis. Unsupervised hierarchical clustering of the identified 77
probe sets revealed that E2 did not have an exclusive effect on gene expres-
sion. Blue indicates low expression and yellow indicates high expression. In
the colored horizontal side bar, green indicates HBC (n  6) and red indicates
E2 (n  6).
Figure 2 Heat Map of Sexually Dimorphic E2-Regulated Human
(A) Unsupervised hierarchical clustering of the identified 41 probe sets divided th
E2 (n  3/sex) was calculated for each tissue and then the effect of the sex on t
differences. (B) Microarray data analysis revealed that E2 induced the expression
diac tissues from women. All analyses were performed with independent tissue sawere small fold changes (20% to 40%) in gene expression
between the 2 conditions.
Sex-specific regulation of gene expression by E2 in
human cardiac tissues. We then asked whether E2 regu-
lates cardiac gene expression in a different manner between
male and female tissues. We first calculated the differences
in expression between the 2 conditions of E2 and HBC
treatment for each tissue. We then fitted a statistical model
stratifying the data by the effect of the sex. This approach
identified 41 probe sets (p  0.001) (Online Table 2).
Unsupervised hierarchical clustering of these probe sets
confirmed the effect of the sex through the separate group-
ing of E2 effects in male and female divisions (Fig. 2A).
Among these candidates, we identified the MYLIP gene,
whose expression was induced by E2 in heart tissues of men
only (Fig. 2B).
E2 regulates Mylip in a sex-dependent manner in mouse
CMs. We selected Mylip as the most interesting candidate
because of its potential influence on contraction through
regulation of the myosin regulatory light chain (Mrlc)
(15–18), and we used the mouse for further analysis. Due to
the multicellular nature of the heart tissue, to test the
hypothesis that this regulation occurred in the CM, we
treated mice in vivo with E2, and we subsequently deter-
mined the level of Mylip in isolated CMs. In addition, this
approach enabled us to test whether the regulation of Mylip
by E2 is conserved between humans and mice. Quantitative
real-time reverse transcription PCR confirmed that E2
modulated the expression of Mylip in a sex-specific manner
(interaction p  0.05). In particular, the treatment with E2
induced the expression of Mylip in CMs of male mice
(adjusted p  0.05), whereas the same treatment had no
significant effect in female CMs (adjusted p  0.99) (Fig. 3).
Therefore, we have identified a novel regulatory effect of E2
iac Gene Expression
o 2 distinct groups. The difference of expression between HBC (n  3/sex) and
s analyzed. Blue indicates low expression, and yellow indicates high expression
LIP in cardiac tissues from men, whereas there was no significant change in car-
. Each tissue originated from a different individual. ***p  0.001.Card
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January 24, 2012:410–7 E2-Induced Mylip in Male CMs Impairs Contractionthat is CM- and sex-specific and conserved between hu-
mans and mice.
Increased Mylip and reduced Mrlc protein levels in CMs
of male E2-treated mice only. Next, we investigated
whether Mylip protein levels were altered in the same
direction as at the transcriptional level. In particular, after
E2 exposure, Mylip protein levels were significantly in-
creased in males (adjusted p  0.01), whereas they did not
change in females (adjusted p  0.76) (Fig. 4A). Mylip
ediates ubiquitination and subsequent proteasomal degra-
ation of Mrlc (15,18). On the basis of this, we hypothe-
ized that E2 modulates Mrlc through increased Mylip
rotein levels. Immunoblotting revealed the sex-dependent
bundance of Mrlc protein after treatment with E2. In line
ith our hypothesis, we found that there was a significant
ecrease (adjusted p  0.05) in Mrlc levels in males treated
ith E2 compared with the male-derived control group,
hereas in females, it remained stable (adjusted p  0.99)
Fig. 4B).
ardiac Mrlc is an endogenous substrate of Mylip,
nd increased Mylip abundance enhances in vivo Mrlc
biquitination. Evidence supporting the notion that
ylip regulates cardiac Mrlc levels has been lacking. Our
eport offers novel insight into this mechanism. We hypoth-
sized that Mrlc represents an in vivo substrate for Mylip
ctivity in the heart. Coimmunoprecipitation analyses of
ale left ventricular lysates revealed the binding of Mylip to
rlc, which was further augmented after E2 exposure (Fig.
A). Accordingly, the expected basal ubiquitination levels of
rlc were further increased following E2 treatment (Fig. 5B),
Figure 3 Mylip Expression Levels in E2-Treated Mouse CMs
Mice were treated in vivo with 0.2 mg/kg E2 or HBC for 5 h followed by cardio-
myocyte (CM) isolation. Quantitative real-time PCR confirmed that E2 induced
Mylip in CMs of male mice, whereas in female CMs, there was no effect. Data
are mean  SEM of independent biological replicates, and each was measured
in duplicate. n  4/group; *p  0.05. NS  nonsignificant.upporting our hypothesis.2 impairs contractile function in male CMs only. We
hen postulated that the E2-triggered increase in Mylip
evels characterized by the decrease in Mrlc abundance in
ale CMs leads to impaired contractile function in these
ells. We recorded unloaded cell shortening at 1, 2, and 4
z. CMs from male mice treated with E2 showed a
ignificantly smaller cell contraction compared with the
BC-treated group (Figs. 6A and 6C). On the other hand,
here was an increasing trend in cell contraction in female
Ms after E2 compared with controls (Figs. 6B and 6C).
imilarly, there was a significant decrease in the rate of
ontraction of E2-treated male CMs compared with con-
rols, whereas the opposite trend was observed in female
Ms (Fig. 6D).
YLIP expression levels rise with increasing age in male
uman hearts. Knowing that E2 levels increase in aging
en (6,13,19), we sought to support the clinical relevance of
ur findings. We therefore studied the expression levels of
YLIP in the hearts of younger and older men. Quantita-
ive real-time reverse transcription PCR revealed that there
s a higher MYLIP expression in the hearts of men older
han 50 years than in the hearts of men younger than 40
ears (Fig. 7A). Moreover, we employed 2 public microarray
atasets that enabled us to stratify our analysis by age. Using
his additional cohort, we further confirmed that in the
earts of men older than 50 years (n  4), MYLIP
expression was higher than in the hearts of men younger
than 40 years (n  4; adjusted p  0.002) (Fig. 7B).
Discussion
Our novel findings are that E2 has direct effects in the heart
through the regulation of gene expression; these effects can
be sex- and CM-specific; E2 regulates Mylip in a conserved
fashion in humans and mice; cardiac Mrlc is a substrate for
Mylip activity; and E2 impairs cellular contractility in male
CMs.
We performed genome-wide profiling of E2-treated human
cardiac tissues. The variation in human material was con-
siderable, and the changes in gene expression were not large.
Small fold changes due to E2 effects have already been
encountered by our group and others (20–22). Small quan-
titative differences in the amount of RNA might have
relevant qualitative effects at a functional level. To this
extent, we recently suggested that the heart is a highly
regulated environment, where minor changes may have
major effects (9). Here, we provide evidence supporting this
notion.
Following the generation of the candidate list, the expo-
sure of the tissues to E2 was not sufficient to be the sole
factor responsible for the variation in the expression of the
identified 77 probe sets between HBC- and E2-treated
tissues, as demonstrated by the corresponding clustering.
This finding further suggested that the sex might play an
important role in the regulation of gene expression by E2.
Divergent hormonal effects on gene expression in male and
414 Kararigas et al. JACC Vol. 59, No. 4, 2012
E2-Induced Mylip in Male CMs Impairs Contraction January 24, 2012:410–7female mice were suggested earlier (23), a finding that we
recently confirmed in the human heart for progesterone
receptor (9). We now demonstrate that E2 regulates gene
expression in a sex-specific manner, particularly in CMs.
We have not yet deduced the mechanisms responsible. One
possibility could be differences in the expression levels of the
ER between the sexes. However, the expression profiling
did not reveal any significant changes. On the other hand,
Figure 4 Mylip and Mrlc Protein Levels in E2-Treated Mouse H
(A) Immunoblotting analysis with antibodies specific for the indicated proteins rev
whereas there was no significant difference in female hearts. Black lines indicate
els were decreased in E2-treated male hearts, whereas they remained stable in fe
try analysis is shown. Tubulin was used as loading control. Results are representa
mice per group  SEM. *p  0.05; **p  0.01. NS  nonsignificant.
Figure 5 Endogenous Mylip–Mrlc Interaction and In Vivo Mrlc U
(A) Coimmunoprecipitation (IP) analysis revealed that Mylip interacts with Mrlc in
amounts of left ventricular lysates were incubated with anti-Mylip followed by imm
Black lines indicate that intervening lanes have been spliced out. (B) Following di
shown by immunoblot (IB) analysis, it was found that ubiquitination of Mrlc was en
an anti-Ub antibody and analyzed by immunoblotting using an anti-Mrlc antibody. In
Results are representative of 2 or more individual experiments.the E2-ER complex interacts with other transcriptional
cofactors of different function, thereby modulating tran-
scriptional regulation (7,8). We postulate that the identified
sex-specific regulation of gene expression by E2 is the result
of differences in the recruitment of transcriptional cofactors
between the sexes.
A novel observation is that ex vivo treatment of human
cardiac tissues with E2 increased the levels of MYLIP in
that the abundance of Mylip was increased in male hearts after E2 exposure,
tervening lanes have been spliced out. (B) On the other hand, Mrlc protein lev-
earts. (A and B) Semiquantification of protein profiling by means of densitome-
f 2 or more individual experiments and are presented as the mean value of 5
itination
art. Notably, this interaction was further enhanced after E2 exposure. Equal
tting of immunoprecipitates with anti-Mrlc. Input lanes, 1% of initial extracts.
es in overall Mrlc protein levels between male E2-treated mice and controls as
d after E2 exposure. Equal amounts of proteins were immunoprecipitated using
nes, 1% of initial extracts. (A and B) Tubulin was used as loading control.earts
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January 24, 2012:410–7 E2-Induced Mylip in Male CMs Impairs Contractiontissues from men, but not from women, compared with
control tissues. To verify the idea that this regulation occurs
in the CM, we treated mice in vivo with E2, and we
subsequently determined the level of Mylip in isolated CMs.
s in humans, E2 induced the expression of Mylip in male,
ut not in female, mouse CMs. We also confirmed that
ylip protein levels were altered in the same direction.
ylip is an E3 ubiquitin ligase that belongs to the ezrin-
adixin-moesin (ERM) protein family, and it contains a
-terminal RING finger domain (18). In neuronal cells,
ylip has been shown to bind Mrlc, mediating its ubiq-
itination and subsequent proteasomal degradation (15,18).
ased on this knowledge, we hypothesized that the induc-
ion of Mylip by E2 would result in decreased Mrlc levels.
Figure 6 Cellular Contraction of CMs From Mice Treated With
The treatment with E2 led to a significant impaired contractile function in male ca
(A and B) Examples of a time course of unloaded cell shortening during steady-st
ing (L) normalized to diastolic cell length (L0) and (D) rate of contraction at 2 Hz.
HBC; 34 cells female E2. **p  0.01.ndeed, there was a significant decrease in Mrlc protein fevels due to E2 in male CMs, whereas there was no change
n the Mrlc content of female CMs. However, the possi-
ility that cardiac Mrlc is a substrate of Mylip had not been
xplored previously. We now demonstrate the endogenous
nteraction of Mylip with Mrlc. As expected, this binding
as further augmented after E2 exposure. Subsequently, we
etermined that the in vivo ubiquitination of Mrlc was
nhanced in E2-treated CMs.
Modulation of contraction by Mrlc in the heart has been
ell documented (16,17). Phosphorylation of Mrlc by
yosin light chain kinase decreases the distance between
yosin and actin, with an increase in Ca2 sensitivity of the
yofilaments and a higher rate of contraction. At baseline,
here is a significant level of phosphorylation. Mutant mice
ocytes (CMs), whereas there was an enhancing trend in female CMs.
mulation at 2 Hz (normalized to control). (C) Mean data of unloaded cell shorten-
rs indicate SEM. n  33 cells male HBC; 36 cells male E2; 44 cells femaleE2
rdiomy
ate sti
The baor Mrlc phosphorylation show defects in heart contraction
416 Kararigas et al. JACC Vol. 59, No. 4, 2012
E2-Induced Mylip in Male CMs Impairs Contraction January 24, 2012:410–7(24). Although no data exist regarding changes in the levels
of Mrlc expression, we postulated that decreased Mrlc levels
would lead to impaired contractile function. Indeed, re-
duced Mrlc levels would preclude the positive modulatory
effect of phosphorylation of Mrlc. Cell shortening measure-
ments demonstrated that with E2 there was a significant
impairment of cellular contractility in male CMs only. Our
data support the regulatory role of Mrlc and reveal a novel
sex-dependent mechanism. The reduced extent and rate of
contraction suggest that reduction of Mrlc reproduces the
effects of removal of phosphorylation.
In men, E2 is produced in significant quantities by local
tissue aromatization of androgenic precursors from the testes
and adrenal glands (25). In obese men, there is a marked
increase of E2 production (26). In addition, E2 levels in men
increase further with advancing age (6,13), and elderly men
may have higher concentrations of E2 compared with
age-matched women (19). Elevated E2 levels in men are
associated with myocardial infarction and coronary artery
disease (27) and with an increased risk of stroke (13). Notably,
high E2 concentrations are a significant predictor of poor
prognosis and higher mortality in men with chronic heart
failure and reduced left ventricular ejection fraction (4).
Although elevated E2 levels in older and/or obese men
have been associated with an increased risk and incidence of
cardiovascular disease, explanations for causal pathways and
putative mechanisms for this association have not been
identified (4). We suggest that MYLIP could contribute to
Figure 7 MYLIP Expression Levels
in Hearts of Younger and Older Men
(A) Quantitative real-time PCR revealed that the expression levels of MYLIP are
higher in the left ventricles of men older than 50 years (n  9) compared with
those of men younger than 40 years (n  6). Data are mean  SEM of inde-
pendent biological replicates, and each was measured in duplicate. (B) Analy-
sis of publicly available independent microarray datasets of cardiac tissues
also revealed that in men older than 50 years, MYLIP expression is higher
compared with men younger than 40 years (n  4/group). Analyses were per-
formed with independent tissue samples. Each tissue originated from a differ-
ent individual. *p  0.05; **p  0.01. y  years.this association, and we propose that MYLIP could becomea pharmacological target in this high-risk group. Relevant to
this notion and to support the clinical relevance of our
findings, we found that MYLIP expression is higher in the
hearts of men older than 50 years than in the hearts of men
younger than 40 years. However, no measurements of E2
levels in these same individuals exist so that a direct
association could be tested. Furthermore, questions remain
about the precise actions of MYLIP that could increase
cardiovascular risk. However, it was recently reported that
MYLIP is involved in cholesterol regulation through the
ubiquitination of the low-density lipoprotein receptor (28).
Clearly, avenues for further research in this area are open.
Study limitations. We acknowledge that the sample size
for human material was rather small, related to limited fresh
material available from closely matched individuals, as well
as a low number of publicly available datasets. Yet the
internal consistency across the different experiments sup-
ports the conclusions. We have also limited ourselves for
mouse experiments to 1 dose of E2. The dose was chosen
based on literature data that indicate that this dose leads to
in vivo E2 levels that at peak are 2.5-fold higher than
baseline and within the range of values found in elderly
men. Studying the effect of various doses of E2 in vivo
would be of interest, but it would require a large number of
animals not justified by the current question, namely to
confirm a CM-specific effect.
Conclusions
We have shown that E2 exerts direct effects on gene
expression in the heart and these actions may be different
between the sexes. The present findings may offer insight
into possible molecular mechanisms responsible for some of
the sex-related differences observed in the development,
prognosis, and outcome of cardiovascular disease, and they
underscore the potential benefit from sex-specific therapies.
Lastly, our work provides evidence and grounds for the
notion that E2 is a master regulator through the modulation
of gene expression, strongly suggesting an explanatory path
for the prominent role of E2 in the development of sexually
dimorphic traits in health and disease.
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